1. Home
  2. USNA vs ARCT Comparison

USNA vs ARCT Comparison

Compare USNA & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo USANA Health Sciences Inc.

USNA

USANA Health Sciences Inc.

HOLD

Current Price

$14.54

Market Cap

397.1M

Sector

Health Care

ML Signal

HOLD

Logo Arcturus Therapeutics Holdings Inc.

ARCT

Arcturus Therapeutics Holdings Inc.

HOLD

Current Price

$13.87

Market Cap

163.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
USNA
ARCT
Founded
1992
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
397.1M
163.4M
IPO Year
1996
2019

Fundamental Metrics

Financial Performance
Metric
USNA
ARCT
Price
$14.54
$13.87
Analyst Decision
Buy
Analyst Count
0
10
Target Price
N/A
★ $24.11
AVG Volume (30 Days)
169.8K
★ 952.2K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 20.00
EPS
★ N/A
N/A
Revenue
★ $1,060,902,000.00
$82,031,000.00
Revenue This Year
$3.90
N/A
Revenue Next Year
$6.21
$12.77
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$12.57
$5.50
52 Week High
$28.52
$24.14

Technical Indicators

Market Signals
Indicator
USNA
ARCT
Relative Strength Index (RSI) 46.71 50.49
Support Level $12.57 $13.12
Resistance Level $15.75 $17.85
Average True Range (ATR) 0.52 1.28
MACD 0.11 -0.50
Stochastic Oscillator 33.14 15.91

Price Performance

Historical Comparison
USNA
ARCT

About USNA USANA Health Sciences Inc.

Usana Health Sciences Inc develops and manufactures high-quality nutritional supplements, functional foods, and personal care products that are sold throughout the world. The company has developed and manufactured high-quality, science-based nutritional, personal care, and skincare products with a primary focus on promoting long-term health and wellness. The Company's reporting units for goodwill purposes are tied to its reportable segments: Core nutritional and Hiya direct-to-consumer. The core nutritional segment consists of three individual reporting units that are determined based on the operational nature of the business: Buy-Sell, China, and India. Geographically, it is in Asia Pacific, the Americas, and Europe. With the majority of revenue from Asia Pacific(Greater China).

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.

Share on Social Networks: